Abstract
We describe a new mechanism by which CTG tract expansion affects myotonic dystrophy (DM1). Changes to the levels of a panel of RNAs involved in muscle development and function that are downregulated in DM1 are due to aberrant localization of the transcription factor SHARP (SMART/HDAC1-associated repressor protein). Mislocalization of SHARP in DM1 is consistent with increased CRM1-mediated export of SHARP to the cytoplasm. A direct link between CTG repeat expression and SHARP mislocalization is demonstrated as expression of expanded CTG repeats in normal cells recapitulates cytoplasmic SHARP localization. These results demonstrate a role for the inactivation of SHARP transcription in DM1 biology.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibiotics, Antineoplastic / pharmacology
-
Cell Nucleus / metabolism*
-
Cytoplasm / metabolism
-
DNA-Binding Proteins
-
Fatty Acids, Unsaturated / pharmacology
-
Gene Expression Regulation
-
Homeodomain Proteins / genetics
-
Homeodomain Proteins / metabolism*
-
Humans
-
Myoblasts / metabolism
-
Myotonic Dystrophy / genetics
-
Myotonic Dystrophy / physiopathology*
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism*
-
Protein Transport / drug effects
-
RNA / metabolism*
-
RNA Splicing / genetics
-
RNA-Binding Proteins / metabolism
-
Trinucleotide Repeat Expansion / genetics
Substances
-
Antibiotics, Antineoplastic
-
DNA-Binding Proteins
-
Fatty Acids, Unsaturated
-
Homeodomain Proteins
-
MBNL3 protein, human
-
Nuclear Proteins
-
RNA-Binding Proteins
-
SIX5 protein, human
-
SPEN protein, human
-
RNA
-
leptomycin B